Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Molecule, By Test, By Workflow And Segment Forecasts From 2022 To 2030

Report ID: MN17620362  |  Published: November 2022  |  No of Pages: 165
Format: Electronic (PDF)  |  Industry: Biotechnology

The global bioanalytical testing services market size is estimated to reach USD 7.65 billion by 2030, registering a CAGR of 8.6% from 2022 to 2030. The uptrend in the outsourcing of R&D activities by various biopharmaceutical companies for streamlining their fundamental competencies is one of the significant factors driving the market growth. In addition, the COVID-19 outbreak helped in augmenting the demand for testing services as the quick surge in infection cases prominently boosted the production of a humungous batch of vaccines across the world.

The increase in the demand for pharmaceutical products across the world has steered the development of pipeline drugs that need bioanalytical testing, thus fueling the market growth. Additionally, the market is anticipated to witness substantial growth during the forecast period owing to the surge in the number of contract manufacturing companies that are focusing on expanding their production capacities across the world.

Based on molecule, the small molecules segment dominated the global market, accounting for a share of over 56.1% in 2021. The escalating demand for the development of generic drugs is driving the growth of the segment. Furthermore, the branded and generic drug compounds are primarily small molecules. The generic drug manufacturers are required to undertake and present bioanalytical testing results owing to the growth in the expiration of patents. This is propelling the implementation of small molecule bioanalytical testing.

Based on workflow, the sample analysis workflow held the largest market share of over 45.5% in 2021. Sample analysis has a crucial role to play in the drug development and marketing phases. It aids in the quantitation and identification of impure compounds in a sample and assesses the stability of drug molecules. Thus, the increasing rate of drug development is one of the significant factors boosting the market demand for sample analysis, thereby boosting the segment’s growth.

Based on test, the market is segmented into Absorption Distribution Metabolism Excretion (ADME), Pharmacodynamics (PD), Pharmacokinetics (PK), bioequivalence, bioavailability, and others. The bioavailability segment dominated the global market in 2021, accruing a revenue share of over 18.5%. This is attributable to the rise in demand for these services in generic drug development. In addition, the increasing concerns among consumers regarding self-care are fueling the adoption of various pharmaceutical products.

North America held the largest market share in the global bioanalytical testing services market, accounting for over 46% in 2021. The regional market is expected to further expand at a stable growth rate, maintaining the leading position throughout the forecast period. This can be credited to the increasing number of pharmaceutical vendors in countries, including the U.S. and Canada. The robust presence of numerous significant market players is another vital factor anticipated to contribute to the market growth in the region.

The key players in the market are undertaking various strategic initiatives, including collaborations, portfolio expansion, and mergers & acquisitions in order to maintain their foothold in the market. For instance, in October 2021, SGS SA proclaimed the expansion of its biosafety testing facility in Glasgow. The vendors are also enhancing their market position by offering different types of services and developing innovative methods, assay validations, and other laboratory solutions. Furthermore, in the wake of the pandemic, various companies expanded their capacities of providing testing services for new viral coercions by utilizing rapid and advanced testing platforms. Such initiatives are expected to be opportunistic for the market.

Bioanalytical Testing Services Market Report Key Takeaways

  • Based on molecule, the small molecule segment dominated the global market, accounting for a share of 56% in 2021. The escalating demand for the development of generic drugs is driving the growth of the segment
  • Based on test, the bioequivalence segment is projected to garner the fastest growth rate from 2022 to 2030. This is attributable to the surging rate of drug manufacturing outsourcing services across the world
  • Based on workflow, the sample analysis segment held the largest revenue share in 2021
  • North America dominated the global market in 2021 owing to the robust presence of an enormous number of pharmaceutical players in the U.S.
  • The Asia Pacific is anticipated to register the fastest growth rate during the forecast period


Bioanalytical Testing Services Market Segments

  • Bioanalytical Testing Services Molecule Outlook (Revenue, USD Billion, 2018 - 2030)
    • Small Molecule
    • Large Molecule
      • LC-MS Studies
      • Immunoassays
        • PK
        • ADA
        • Others
    • Others
  • Bioanalytical Testing Services Test Outlook (Revenue, USD Billion, 2018 - 2030)
    • ADME
      • In-Vivo
      • In-Vitro
    • PK
    • PD
    • Bioavailability
    • Bioequivalence
    • Others
  • Bioanalytical Testing Services Workflow Outlook (Revenue, USD Billion, 2018 - 2030)
    • Sample Preparation
      • Protein Precipitation
      • Liquid-Liquid Extraction
      • Solid Phase Extraction
    • Sample Analysis
      • Hyphenated Technique
      • Chromatographic Technique
      • Electrophoresis
      • Ligand Binding Assay
      • Mass Spectrometry
      • Nuclear Magnetic Resonance
    • Other Workflow Processes
  • Bioanalytical Testing Services Therapeutic Area Outlook (Revenue, USD Billion, 2018 - 2030)
    • Oncology
    • Neurology
    • Metabolic Disorders
    • Hematology
    • Immunology
    • Orthopedics
    • Others
  • Bioanalytical Testing Services End-user Outlook (Revenue, USD Billion, 2018 - 2030)
    • Pharmaceutical and Biotechnology Companies
    • Contract Development and Manufacturing Organization
    • Contract Research Organization
    • Others
  • Bioanalytical Testing Services Regional Outlook (Revenue, USD Billion, 2018 - 2030)
    • North America
      • U.S.
      • Canada
    • Europe
      • France
      • U.K.
      • Germany
      • Italy
      • Spain
      • The Netherlands
      • Switzerland
      • Sweden
    • Asia Pacific
      • Japan
      • China
      • India
      • Indonesia
      • Malaysia
      • Singapore
      • South Korea
      • Thailand
      • Taiwan
      • Australia
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Israel
  • List of Key Players in Bioanalytical Testing Services Market
    • PPD, Inc.
    • ICON Plc
    • Charles River Laboratories International
    • Covance, Inc.
    • IQVIA
    • Syneos Health
    • SGS SA
    • Toxikon
    • Intertek Group Plc
    • Pace Analytical Services LLC
What questions do you have? Get quick response from our industry experts. Request More information
Key questions answered in the report include
key questions
We also offers customization on reports based on specific client requirement.
Request for Customization

Choose License Type

Research Assistance

Ryan Manuel
Ryan Manuel

Research Support Specialist, USA

  1. Phone: +1-408-610-2300
  2. Toll Free: +1-866-831-4085
  3. Email: [email protected]
Connect With Expert
  • World's largest premium report database
  • Transparent pre & post sale customer engagement model
  • Unparalleled flexibility in terms of rendering services
  • Safe & secure web experience
  • 24*5 Research support service

Get a Free Sample

FREE sample contains market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...